Cybin (HELP) Revenue (2020 - 2024)

Cybin (HELP) reported Revenue of $14.9 million for Q4 2024, up 712.03% on a YoY basis from $1.8 million in Q1 2024, and up 712.03% quarter-over-quarter from -$2.4 million in Q4 2023.

Cybin (HELP) Revenue (2020 - 2024) Analysis & Trends

Cybin has reported Revenue for 3 years, with the latest figure at $14.9 million in Q4 2024.

  • For the quarter ending Q4 2024, Revenue rose 712.03% year-over-year to $14.9 million; the trailing twelve-month figure through Dec 2024 stood at $13.1 million (changed N/A YoY), and the FY2021 full-year result was $682645.6, changed N/A from the prior year.
  • Revenue for Q4 2024 stood at $14.9 million, up from -$2.4 million in the prior quarter.
  • The five-year high for Revenue was $14.9 million in Q4 2024, with the low at -$2.4 million in Q4 2023.
  • Historically, Revenue has averaged $4.4 million across 3 years, with a median of $623120.2 in 2020.
  • The largest YoY upside for Revenue was 712.03% in 2024 against a maximum downside of 712.03% in 2024.
  • Cybin's Revenue stood at $623120.2 in 2020, then plunged by 489.71% to -$2.4 million in 2023, then soared by 712.03% to $14.9 million in 2024.
  • The last three Revenue figures came in at $14.9 million (Q4 2024), -$2.4 million (Q4 2023), and $623120.2 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 14.86 Mn
Dec 31, 2023 -2.43 Mn
Jun 30, 2020 623,120.21